Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Rheumatoid Arthritis
Marketing
EMA cracks down on JAK drugs with new limitations
The EMA restrictions follow FDA's policy rolled out last year limiting JAK inhibitors' use behind a TNF blocker in inflammatory diseases.
Angus Liu
Oct 28, 2022 10:20am
ANI focuses on data insights to ramp up Cortrophin
Jun 24, 2022 8:10am
NIH study finds arthritis meds reduce COVID death risk
Jun 2, 2022 4:33pm
Trial win sets up AbbVie's Rinvoq up for likely Crohn's approval
May 12, 2022 9:52am
Lilly's Olumiant gets full FDA nod for COVID patients on oxygen
May 11, 2022 8:50am
The top advertisers in Big Pharma
Apr 25, 2022 3:00am
